Fauci says he's back on Paxlovid after 'rebound' of COVID-19 symptoms
After testing positive for COVID-19 earlier this month, White House chief medical adviser Dr. Anthony Fauci revealed Wednesday he's experiencing a
After testing positive for COVID-19 earlier this month, White House chief medical adviser Dr. Anthony Fauci revealed Wednesday he's experiencing a
No high school diploma? Be all you can be in the military. No COVID shot after years of meritorious service? Goodbye, as we ask illegal aliens to
BioNTech, Pfizer to start testing universal vaccine for coronaviruses 9:45 AM EDT By Ludwig Burger June 29 (Reuters) – Germany’s BioNTech
U.S. FDA advisers recommend change to COVID vaccine composition for fall By Michael Erman and Leroy Leo June 28 (Reuters) – Advisers to the U.S.
"Sesame Street" is promoting COVID-19 vaccines to children under 5 after the U.S. Food and Drug Administration granted emergency
Pfizer, Roivant unveil Priovant with high potential TYK2/JAK1 inhibitor Published: Jun 28, 2022 By Vanessa Doctor, RN BioSpace Pfizer and Roivant
Omicron sub-variants BA.4, BA.5 make up more than 50% of U.S. COVID cases – CDC 10:43 AM EDT June 28 (Reuters) – The fast-spreading BA.4 and BA.5
U.S. FDA will decide on redesigned COVID vaccines by early July June 28, 2022, 9:58 AM EDT By Michael Erman June 28 (Reuters) – U.S. regulators
Pfizer has released yet another injection that they are calling a “vaccine” that supposedly targets the Omicron variant of COVID-19. Considering
COVID vaccines have finally been authorised and recommended for kids as young as 6 months old, and little kids across the country are finally able to
U.S. CDC backs Moderna’s COVID vaccine for teens, older children June 24, 2022, 11:02 AM EDT June 24 (Reuters) – The U.S. Centers for Disease
Analysis: The next COVID booster shots will likely be updated for Omicron June 24, 2022, 7:22 AM EDT By Michael Erman NEW YORK, June 24 (Reuters) –
U.S. delivers over 4 million doses of COVID vaccine for young children June 23, 2022, 11:15 AM EDT By Ahmed Aboulenein WASHINGTON, June 23 (Reuters)
Pfizer-backed DEM Bio launches to leverage CRISPR in immuno-oncology Published: Jun 23, 2022 By Vanessa Doctor, RN BioSpace DEM BioPharma, backed
GSK, Novartis pledge funds for diseases that mostly affect the poor June 23, 2022, 7:02 AM EDT By Natalie Grover and Jennifer Rigby LONDON, June 23